EIF2A and viral infectious disease: For example, the small molecular ISRIB, which overcomes eIF2a phosphorylation-mediated inhibition of translation by stimulating eIF2B activity, effectively rescues protein translation inhibition under conditions of acute viral infection with low levels of p-eIF2a but is ineffective in chronic infection with high levels of p-eIF2a present [74].